Treosulfan and Total-marrow Irradiation (TMI) Based Conditioning With Rapamycin-based GvHD Prophylaxis for Allogenic Stem Cell Transplantation in Patients With High-risk Hematological Malignancies.
Conditions: Irradiated Bone Marrow; Transplant-Related Hematologic Malignancy; Leukemia, Acute; Multiple Myeloma; Graft Vs Host Disease Interventions: Drug: Conditioning treatment " Treosulfan-TMI " ; Procedure: SCT; Drug: GvHD prophylaxis Sponsor: IRCCS San Raffaele Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Cancer & Oncology | Hematology | Leukemia | Myeloma | Research | Stem Cell Therapy | Stem Cells | Transplants